ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 106 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $161 | +1.9% | 48,473 | +0.4% | 0.00% | – |
| Q1 2024 | $158 | 0.0% | 48,273 | +7.7% | 0.00% | – |
| Q4 2023 | $158 | -40.8% | 44,827 | +12.4% | 0.00% | – |
| Q3 2023 | $267 | -18.8% | 39,892 | +1.9% | 0.00% | – |
| Q2 2023 | $329 | -33.3% | 39,150 | -21.0% | 0.00% | – |
| Q1 2023 | $493 | +42.9% | 49,587 | 0.0% | 0.00% | – |
| Q4 2022 | $345 | -99.8% | 49,587 | +44.2% | 0.00% | – |
| Q3 2022 | $184,000 | +1.7% | 34,387 | -24.1% | 0.00% | – |
| Q2 2022 | $181,000 | -12.1% | 45,310 | -2.3% | 0.00% | – |
| Q1 2022 | $206,000 | +39.2% | 46,364 | +25.1% | 0.00% | – |
| Q4 2021 | $148,000 | +51.0% | 37,064 | +232.0% | 0.00% | – |
| Q3 2021 | $98,000 | -23.4% | 11,164 | -0.9% | 0.00% | – |
| Q2 2021 | $128,000 | – | 11,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
| Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
| Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
| Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
| Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
| APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
| JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
| Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |